Huntington National Bank »

Ovid Therapeutics shares owned by Huntington National Bank

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2026-06-30 $371 213 1.74

More positions owned by Huntington National Bank

Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
JP MORGAN CHASE & Common Stock (JPM)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IVV)
Microsoft Corp Common Stock (MSFT)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
Ishares Exchange Traded (Principal) (IJH)
Ishares Exchange Traded (Principal) (IJR)
ELI LILLY & Common Stock (LLY)
Advanced Micro Devices Common Stock (AMD)
State Street Exchange Traded (Principal) (SPY)
Exxon Mobil Corp Common Stock (XOM)

View all positions for Huntington National Bank

Top funds holding Ovid Therapeutics

Jupiter Topco
Eventide Asset Management
BlackRock
Henderson Group
RA Capital Management
Affinity Asset Advisors
Vanguard Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Federated Investors
Braidwell
Geode Capital Management
Silverarc Capital Management
Stempoint Capital

View all funds holding Ovid Therapeutics